First Page | Meta Content | |
---|---|---|
Document Date: 2013-01-29 08:49:12Open Document File Size: 205,16 KBShare Result on FacebookCityAthlone / Ardsley / /CompanyAlkermes Pharma Ireland Limited / Acorda Therapeutics Inc. / 2013Acorda Therapeutics Inc. / /CountryUnited States / Canada / Ireland / /EventFDA Phase / /Facilitystore AMPYRA / The terminal / I store AMPYRA / /IndustryTermfood / aqueous oral solution / chemical name / /MedicalConditionAnaphylaxis AMPYRA / headache / seizures / serious allergic reactions / hives / urinary tract infection / lymphoma tk / nausea / Anaphylaxis / balance disorder / multiple sclerosis / hypersensitivity / Urinary Tract Infections / memory loss / constipation / MS / confusional state / Back pain / post-marketing period seizures / asthenia / back pain / severe allergic reactions / insomnia / Seizures AMPYRA / complex partial seizure / indigestion / disease / nasopharyngitis / shortness of breath / amnesia / Carcinogenesis / itching / seizure / pain / urticaria / angioedema / irritation / Urinary Tract Infections Urinary tract infections / dizziness / limbic encephalitis / fertility Carcinogenesis / paresthesia / status epilepticus / /OrganizationOral administration / U.S. Food and Drug Administration / _______________DOSAGE AND ADMINISTRATION / FDA / / /Positionpharmacist / Major / /ProductTake / Extended Release tablets / Single AMPYRA tablet / A10 / polyethylene glycol / AMPYRA tablets / Take AMPYRA tablets / baclofen / This Medication / dalfampridine / AMPYRA / /ProvinceOrStateNew York / /TechnologyMRI / Pharmacokinetics / Pharmacodynamics / /URLwww.fda.gov/medwatch / www.AMPYRA.com / /SocialTag |